Evidence map›Paper›PMID 14529314›Full record

ArticleMolecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology2003

MECP2 mutations or polymorphisms in mentally retarded boys: diagnostic implications.

Violaine Bourdon, Christophe Philippe, Dominique Martin, Alain Verloès, Agnès Grandemenge, Philippe Jonveaux

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. International journal of molecular sciences · 2021
    Review
  3. Review
  4. Article
  5. The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2019
    Article
  6. Article
  7. The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1.Autism research : official journal of the International Society for Autism Research · 2012
    Article
  8. Article
  9. MECP2 mutations in males.Journal of medical genetics · 2007
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Violaine BourdonLaboratory of Medical Genetics, EA 3441, CHU-Brabois, Vandoeuvre-Lès Nancy, France.
Christophe Philippe
Dominique Martin
Alain Verloès
Agnès Grandemenge
Philippe Jonveaux
Laboratoire de Génétique MédicaleHôpital Robert-Debré · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmong the well characterized X-linked conditions causing mental retardation, mutations in the methyl-CpG-binding protein 2 gene (MECP2) in Xq28 have been found in up to 85% of patients with Rett syndrome, a neurologic disorder which, in addition to other symptoms, severely affects higher cognitive functions in females. Mutations in the MECP2 gene are involved in a broad spectrum of phenotypes from classical Rett syndrome to mild intellectual difficulties in females and neonatal encephalopathy in males. Recently, mutations in the MECP2 gene were reported in males with non-specific mental retardation suggesting that defects in MECP2 could be responsible for up to 2% of X-linked mental retardation.

methodsWe screened by denaturing high-pressure liquid chromatography the entire coding region and flanking intronic sequences of the MECP2 gene in a cohort of 354 mentally retarded males found negative for an expansion across the FRAXA CGG repeat and in a family in which a boy and his sister were mentally retarded.

resultsWe identified mainly silent polymorphisms within the MECP2 gene, together with four sequence alterations of unknown significance, i.e. three missense mutations (T197M, T228S, and P376S) and one substitution at position -19 in intron 3 (378-19delT). Further familial investigations allowed us to ruled out a pathogenic effect for the intronic variant, the T228S and the P376S missense mutations.

conclusionsThese results confirm that MECP2 mutations in males are far more rare than initially thought and call for a careful evaluation of the pathogenicity of the MECP2 missense mutations identified in mentally retarded males before genetic counseling is proposed to the relatives.

Indexed as

Polymorphism, GeneticChromatography, High Pressure LiquidChromosomal Proteins, Non-HistoneChromosomes, Human, XDNA-Binding ProteinsFemaleHumansIntellectual DisabilityMaleMethyl-CpG-Binding Protein 2MutationPedigreeRepressor ProteinsChromosomal Proteins, Non-HistoneDNA-Binding ProteinsMECP2 protein, humanMethyl-CpG-Binding Protein 2Repressor Proteins

Identifiers

PMID14529314
OpenAlexW29841364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.